Literature DB >> 1009358

Lung changes associated with phenylbutazone treatment.

J G Thurston, P Marks, D Trapnell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1009358      PMCID: PMC1690392          DOI: 10.1136/bmj.2.6049.1422

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Letter: diffuse pulmonary disorder caused by oxyphenbutazone.

Authors:  D C Cameron
Journal:  Br Med J       Date:  1975-05-31

2.  Chronic diffuse interstitial pulmonary fibrosis and rheumatoid arthritis.

Authors:  F I LEE; A T BRAIN
Journal:  Lancet       Date:  1962-10-06       Impact factor: 79.321

3.  Interstitial pulmonary fibrosis following busulfan therapy.

Authors:  H OLINER; R SCHWARTZ; F RUBIO; W DAMESHEK
Journal:  Am J Med       Date:  1961-07       Impact factor: 4.965

4.  Allergic (Löffler's) pneumonitis occurring during antituberculous chemotherapy; report of three cases.

Authors:  D E WOLD; D W ZAHN
Journal:  Am Rev Tuberc       Date:  1956-09

5.  Phenylbutazone and pulmonary oedema.

Authors:  M Nevins; S Berque; N Corwin; L Lyon
Journal:  Lancet       Date:  1969-12-20       Impact factor: 79.321

  5 in total
  2 in total

1.  Alveolitis and haemolytic anaemia induced by azapropazone.

Authors:  M K Albazzaz; J E Harvey; J N Hoffman; J A Siddorn
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

2.  Pulmonary eosinophilia associated with naproxen therapy.

Authors:  K C Flint; N M Johnson
Journal:  J R Soc Med       Date:  1987-02       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.